Clinical Trials
41 trialsinMMyCAR
Kelonia Therapeutics, Inc.
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
TT-CSP-001
TOLREMO therapeutics AG
GPC3
RayzeBio, Inc.
BA-004
bioAffinity Technologies Inc.
Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses
Cosmetique Active International
FIRSTLUNG
Delfi Diagnostics Inc.
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
Anbogen Therapeutics, Inc.
Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)
MiWEndo Solutions S.L.
Spotlight
Blue Earth Diagnostics
REVELATE
Blue Earth Diagnostics
A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).
Anaveon AG
PURSUE
Blue Earth Diagnostics
Cytophone
Cytoastra
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.
Blue Earth Diagnostics
First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies
Chimagen Biosciences, Ltd
ANV419-001
Anaveon AG
A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
Anaveon AG
TIMAR1
Perspective Therapeutics
MiWEndo1
MiWEndo Solutions S.L.
OSPREY
Progenics Pharmaceuticals, Inc.
CAPTIVE
DNAtrix, Inc.
CONDOR
Progenics Pharmaceuticals, Inc.
DBT
Siemens Medical Solutions USA - CSG
RITE-USA
Medical Enterprises Ltd.
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Celgene
Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
Biomoda Inc.
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
GE Healthcare
proSPECT-AS
Molecular Insight Pharmaceuticals, Inc.
Melanoma Image Analysis Algorithm (MIAA) Validation Study
Skin Analytics Limited
CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
Hebei Senlang Biotechnology Inc., Ltd.
Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Jazz Pharmaceuticals
Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Novartis
Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device
Focal Healthcare Inc.
Study of ExAblate Focused Ultrasound Ablation of Breast Cancer
InSightec
Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
Cellectar Biosciences, Inc.
Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
bioAffinity Technologies Inc.
NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma
Sanofi
A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
Ascenta Therapeutics
Use of Hair to Diagnose the Presence of Breast Cancer
Fermiscan Ltd